Details for Patent: 12,274,751
Which drugs does patent 12,274,751 protect, and when does it expire?
Patent 12,274,751 protects GLOPERBA and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 12,274,751
| Title: | Composition and method of the use of colchicine oral liquid |
| Abstract: | Oral liquid colchicine formulations are described herein. Methods of using the oral liquid colchicine formulations are also provided. |
| Inventor(s): | Indu Muni, Naomi Vishnupad |
| Assignee: | Rxomeg Therapeutics LLC |
| Application Number: | US16/707,093 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 12,274,751
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scilex Pharms | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | A METHOD OF PROPHYLACTIC TREATMENT OF GOUT FLARES IN ADULTS COMPRISES ADMINISTERING TO A PATIENT A LIQUID COLCHICINE ORAL SOLUTION | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,274,751
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3426227 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2017156392 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
